Jeffrey Raizer, MD, is Director of Medical Neuro-Oncology at the RH Lurie Comprehensive Cancer Center and Northwestern Memorial Hospital, and Associate Professor of Neurology at Northwestern's Feinberg School of Medicine. Dr. Raizer completed his undergraduate training at UCLA, received his medical degree from New York Medical College, followed by residencies in internal medicine at NYU/Bellevue Hospital Center and Neurology at Yale-New Haven Hospital. He then did a two year fellowship in neuro-oncology at Memorial Sloan Kettering Cancer Center where he then remained on staff for five years before coming to Northwestern to develop the medical neuro-oncology program. Dr. Raizer is currently the Principal Investigator on 14 clinical trials at Northwestern with more in development, and has conducted over 25 clinical trials in the last decade.

"I think of the NBTI as a pyramid," says Dr. Raizer, "with the base being the full complement of medical and surgical care, research efforts, and supportive services, rising to a pinnacle that is the patient. As a clinician, each day I help care for patients who are facing the biggest challenge of their lives. I am always looking for new and better options to offer them. It is exciting to know that the NBTI is in the vanguard of clinical care and patient support as well as translational research efforts that will accelerate the introduction of new and better therapies. What does this mean to me? I want to be able to offer my patients hope for better outcomes, a better quality of life, and, someday, even a cure."

Previous Page